文献速递免疫规划卫生政策与健康促进

ADVANCE:利用欧洲电子健康记录数据库实现疫苗接种覆盖率、获益与风险的近实时监测

ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.
PubMed 文献 · Vaccine · 2019-10-31

ADVANCE公私合作项目以6岁以下儿童无细胞百日咳疫苗接种为测试案例,评估基于欧洲电子健康记录数据库进行疫苗覆盖率、获益与风险近实时监测的可行性。来自4个国家的9个数据库参与定性可行性评估,其中5个参与动态队列研究,3个参与近实时监测并按近乎每周频率提供数据提取。大多数事件的数据延迟中位数为1至2周,仅一个数据库的获益与风险事件延迟为16周。

要点

  • 3个欧洲电子健康记录数据库成功证明可每周提供近实时监测数据。
  • 大多数事件的数据延迟中位数为1至2周,仅一个数据库的获益与风险事件延迟为16周。
  • 共9个数据库参与定性可行性评估,5个参与动态队列研究,3个参与近实时监测。

核心结论

  • 3个欧洲电子健康记录数据库成功证明可为每周近实时监测提供数据,大多数事件的数据延迟较短,为1至2周。

研究设计与样本

  • 采用调查和面对面讨论与ADVANCE数据伙伴进行近实时监测的定性可行性评估。
  • 随后开展动态队列研究,包含两个观察期:第一期为2014年1月至2018年3月用于建立基线,随后3个月用于测试每周近实时监测的实际可行性并据此计算数据延迟。
  • 另开发交互式网络应用以可视化监测疫苗接种覆盖率、疫苗可预防疾病发病率(获益)和不良事件发病率(风险)。
  • 定性可行性评估有来自丹麦、意大利、西班牙和英国的9个数据库参与;动态队列研究有5个数据库参与,其中5个提供基线数据、3个参与近实时监测并按近乎每周频率提供数据提取。

主要发现

  • 数据延迟(事件日期与数据发布日期之间的时间)中位数除一个数据库的获益与风险事件为16周外,其余在1至2周之间。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private partnership aiming to develop and test a system for rapid benefit-risk (B/R) monitoring of vaccines using European electronic health record (eHR) databases. This proof-of-concept study aimed to test the feasibility of near real-time (NRT) monitoring of vaccination coverage, benefits and risks based on multiple European eHR databases, using acellular pertussis vaccination in children aged <6 years as test case. METHODS: A qualitative feasibility assessment on NRT monitoring was carried out using a survey and face-to-face discussion with ADVANCE data partners. Subsequently, a dynamic cohort study was conducted containing two distinct observation periods: a first period to establish a baseline (Jan 2014 to Mar 2018) and a subsequent 3-month period to test the actual feasibility of weekly NRT monitoring, based on which data latencies were calculated. An interactive web-application was additionally developed to facilitate the visual monitoring of vaccination coverage, the vaccine preventable disease incidence rates (benefits) and the incidence rates of adverse events (risks). RESULTS: Nine databases from four countries (Denmark, Italy, Spain and UK) participated in the qualitative feasibility assessment. Of them, five databases took part in the dynamic cohort study, with 5 databases providing baseline data and 3 databases participating to the NRT monitoring, providing data extractions on an almost weekly basis. The median data latency (time between event date and data release date) was between 1 and 2 weeks except for the benefit and risk events in one of the databases (latency 16 weeks). CONCLUSION: Three European eHR databases successfully demonstrated the feasibility of providing data for weekly NRT monitoring, with short data latencies of 1-2 weeks for most events.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bollaerts K, de Smedt T, McGee C, et al. ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases. Vaccine. 2019. PMID: 31677951. doi:10.1016/j.vaccine.2019.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。